ZS Pharma Secures $55,000,000 Series D Financing Round

  • Feed Type
  • Date
    3/6/2014
  • Company Name
    ZS Pharma
  • Mailing Address
    508 Wrangler Drive Coppell, TX 75019
  • Company Description
    Founded in 2008, ZS Pharma, Inc. is a privately held specialty pharmaceutical company located inFort Worth, Texas. It is focused on the development and commercialization of proprietary oral sorbent technology that will significantly improve the clinical outcomes of those patients suffering from toxic conditions associated with kidney and liver disease.
  • Website
    http://www.zspharma.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $55,000,000
  • Transaction Round
    Series D
  • Proceeds Purposes
    Proceeds will be used to advance development of ZS-9, the Company’s lead product candidate for the treatment of hyperkalemia, through its New Drug Application (NDA) and Marketing Authorization Application (MAA) submissions in early 2015.
  • M&A Terms
  • Venture Investor
    Novo Ventures
  • Venture Investor
    RA Capital
  • Venture Investor
    Adage Capital Management
  • Venture Investor
    Sofinnova Ventures
  • Venture Investor
    Alta Partners
  • Venture Investor
    Devon Park Bioventures
  • Venture Investor
    3×5 Special Opportunity Partners
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.